nodes	percent_of_prediction	percent_of_DWPC	metapath
Pyridostigmine—CYP3A4—Temozolomide—skin cancer	0.231	0.292	CbGbCtD
Pyridostigmine—CYP3A4—Imiquimod—skin cancer	0.231	0.292	CbGbCtD
Pyridostigmine—CYP3A4—Vismodegib—skin cancer	0.16	0.202	CbGbCtD
Pyridostigmine—CYP3A4—Vemurafenib—skin cancer	0.127	0.16	CbGbCtD
Pyridostigmine—CYP3A4—Docetaxel—skin cancer	0.0435	0.0548	CbGbCtD
Pyridostigmine—Abnormal behaviour—Temozolomide—skin cancer	0.00655	0.0316	CcSEcCtD
Pyridostigmine—Faecal incontinence—Temozolomide—skin cancer	0.00484	0.0233	CcSEcCtD
Pyridostigmine—Lacrimation—Fluorouracil—skin cancer	0.00383	0.0184	CcSEcCtD
Pyridostigmine—Pulmonary oedema—Imiquimod—skin cancer	0.00363	0.0175	CcSEcCtD
Pyridostigmine—Chest tightness—Docetaxel—skin cancer	0.00346	0.0167	CcSEcCtD
Pyridostigmine—Alopecia—Vismodegib—skin cancer	0.00343	0.0165	CcSEcCtD
Pyridostigmine—Muscle spasms—Vismodegib—skin cancer	0.00325	0.0157	CcSEcCtD
Pyridostigmine—Dry skin—Vemurafenib—skin cancer	0.00318	0.0153	CcSEcCtD
Pyridostigmine—Lethargy—Imiquimod—skin cancer	0.00302	0.0145	CcSEcCtD
Pyridostigmine—Myalgia—Vismodegib—skin cancer	0.00288	0.0139	CcSEcCtD
Pyridostigmine—Lacrimation—Docetaxel—skin cancer	0.00276	0.0133	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Vismodegib—skin cancer	0.00251	0.0121	CcSEcCtD
Pyridostigmine—Sweating increased—Imiquimod—skin cancer	0.00249	0.012	CcSEcCtD
Pyridostigmine—Bronchitis—Imiquimod—skin cancer	0.00246	0.0118	CcSEcCtD
Pyridostigmine—Lacrimation increased—Fluorouracil—skin cancer	0.00244	0.0118	CcSEcCtD
Pyridostigmine—Urinary incontinence—Temozolomide—skin cancer	0.00236	0.0114	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Vismodegib—skin cancer	0.00226	0.0109	CcSEcCtD
Pyridostigmine—Abdominal pain—Vismodegib—skin cancer	0.00218	0.0105	CcSEcCtD
Pyridostigmine—Alopecia—Vemurafenib—skin cancer	0.00212	0.0102	CcSEcCtD
Pyridostigmine—Thrombophlebitis—Temozolomide—skin cancer	0.00205	0.00987	CcSEcCtD
Pyridostigmine—Lethargy—Dactinomycin—skin cancer	0.002	0.00964	CcSEcCtD
Pyridostigmine—Asthenia—Vismodegib—skin cancer	0.00198	0.00954	CcSEcCtD
Pyridostigmine—Eye pain—Temozolomide—skin cancer	0.00196	0.00946	CcSEcCtD
Pyridostigmine—Diarrhoea—Vismodegib—skin cancer	0.00189	0.0091	CcSEcCtD
Pyridostigmine—Thrombophlebitis—Fluorouracil—skin cancer	0.00189	0.00909	CcSEcCtD
Pyridostigmine—Chest discomfort—Docetaxel—skin cancer	0.00183	0.00885	CcSEcCtD
Pyridostigmine—Alopecia—Imiquimod—skin cancer	0.00181	0.00871	CcSEcCtD
Pyridostigmine—Myalgia—Vemurafenib—skin cancer	0.00178	0.00857	CcSEcCtD
Pyridostigmine—Lacrimation increased—Docetaxel—skin cancer	0.00176	0.00849	CcSEcCtD
Pyridostigmine—Vomiting—Vismodegib—skin cancer	0.00175	0.00846	CcSEcCtD
Pyridostigmine—Rash—Vismodegib—skin cancer	0.00174	0.00838	CcSEcCtD
Pyridostigmine—Dermatitis—Vismodegib—skin cancer	0.00174	0.00838	CcSEcCtD
Pyridostigmine—Lethargy—Fluorouracil—skin cancer	0.00167	0.00803	CcSEcCtD
Pyridostigmine—Nausea—Vismodegib—skin cancer	0.00164	0.0079	CcSEcCtD
Pyridostigmine—Agitation—Imiquimod—skin cancer	0.00164	0.00789	CcSEcCtD
Pyridostigmine—Dry skin—Temozolomide—skin cancer	0.00162	0.00783	CcSEcCtD
Pyridostigmine—Blood pressure increased—Docetaxel—skin cancer	0.00162	0.00783	CcSEcCtD
Pyridostigmine—Hypotension—Vemurafenib—skin cancer	0.00159	0.00768	CcSEcCtD
Pyridostigmine—Loss of consciousness—Imiquimod—skin cancer	0.00157	0.00755	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Vemurafenib—skin cancer	0.00155	0.00749	CcSEcCtD
Pyridostigmine—Cardiac arrest—Fluorouracil—skin cancer	0.00155	0.00748	CcSEcCtD
Pyridostigmine—Convulsion—Imiquimod—skin cancer	0.00154	0.00744	CcSEcCtD
Pyridostigmine—Abdominal distension—Temozolomide—skin cancer	0.00154	0.00743	CcSEcCtD
Pyridostigmine—Myalgia—Imiquimod—skin cancer	0.00152	0.00731	CcSEcCtD
Pyridostigmine—Dry skin—Fluorouracil—skin cancer	0.0015	0.00721	CcSEcCtD
Pyridostigmine—Sweating increased—Temozolomide—skin cancer	0.00149	0.00719	CcSEcCtD
Pyridostigmine—Bronchitis—Temozolomide—skin cancer	0.00147	0.0071	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Bleomycin—skin cancer	0.00145	0.00697	CcSEcCtD
Pyridostigmine—Pulmonary oedema—Docetaxel—skin cancer	0.00145	0.00697	CcSEcCtD
Pyridostigmine—Pollakiuria—Temozolomide—skin cancer	0.00141	0.00682	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Imiquimod—skin cancer	0.00141	0.00677	CcSEcCtD
Pyridostigmine—Thrombophlebitis—Docetaxel—skin cancer	0.00136	0.00656	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Imiquimod—skin cancer	0.00132	0.00638	CcSEcCtD
Pyridostigmine—Paraesthesia—Imiquimod—skin cancer	0.00131	0.00629	CcSEcCtD
Pyridostigmine—Somnolence—Imiquimod—skin cancer	0.00129	0.00623	CcSEcCtD
Pyridostigmine—Alopecia—Bleomycin—skin cancer	0.00128	0.00619	CcSEcCtD
Pyridostigmine—Hypersensitivity—Vemurafenib—skin cancer	0.00126	0.00605	CcSEcCtD
Pyridostigmine—Asthenia—Vemurafenib—skin cancer	0.00122	0.00589	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Temozolomide—skin cancer	0.00122	0.00588	CcSEcCtD
Pyridostigmine—Lethargy—Docetaxel—skin cancer	0.0012	0.0058	CcSEcCtD
Pyridostigmine—Alopecia—Dactinomycin—skin cancer	0.0012	0.00577	CcSEcCtD
Pyridostigmine—Feeling abnormal—Imiquimod—skin cancer	0.0012	0.00577	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Imiquimod—skin cancer	0.00119	0.00573	CcSEcCtD
Pyridostigmine—Epistaxis—Fluorouracil—skin cancer	0.00119	0.00572	CcSEcCtD
Pyridostigmine—Diarrhoea—Vemurafenib—skin cancer	0.00117	0.00562	CcSEcCtD
Pyridostigmine—Urticaria—Imiquimod—skin cancer	0.00115	0.00557	CcSEcCtD
Pyridostigmine—Abdominal pain—Imiquimod—skin cancer	0.00115	0.00554	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Fluorouracil—skin cancer	0.00112	0.00542	CcSEcCtD
Pyridostigmine—Vomiting—Vemurafenib—skin cancer	0.00108	0.00522	CcSEcCtD
Pyridostigmine—Alopecia—Temozolomide—skin cancer	0.00108	0.00522	CcSEcCtD
Pyridostigmine—Dry skin—Docetaxel—skin cancer	0.00108	0.00521	CcSEcCtD
Pyridostigmine—Myalgia—Bleomycin—skin cancer	0.00108	0.00519	CcSEcCtD
Pyridostigmine—Rash—Vemurafenib—skin cancer	0.00107	0.00518	CcSEcCtD
Pyridostigmine—Dermatitis—Vemurafenib—skin cancer	0.00107	0.00518	CcSEcCtD
Pyridostigmine—Hypersensitivity—Imiquimod—skin cancer	0.00107	0.00516	CcSEcCtD
Pyridostigmine—Headache—Vemurafenib—skin cancer	0.00107	0.00515	CcSEcCtD
Pyridostigmine—Cramp muscle—Docetaxel—skin cancer	0.00106	0.00512	CcSEcCtD
Pyridostigmine—Asthenia—Imiquimod—skin cancer	0.00104	0.00503	CcSEcCtD
Pyridostigmine—Confusional state—Bleomycin—skin cancer	0.00104	0.00502	CcSEcCtD
Pyridostigmine—Nausea—Vemurafenib—skin cancer	0.00101	0.00488	CcSEcCtD
Pyridostigmine—Myalgia—Dactinomycin—skin cancer	0.001	0.00484	CcSEcCtD
Pyridostigmine—Alopecia—Fluorouracil—skin cancer	0.000998	0.00481	CcSEcCtD
Pyridostigmine—Diarrhoea—Imiquimod—skin cancer	0.000995	0.00479	CcSEcCtD
Pyridostigmine—Agitation—Temozolomide—skin cancer	0.000981	0.00473	CcSEcCtD
Pyridostigmine—Hypotension—Bleomycin—skin cancer	0.000965	0.00465	CcSEcCtD
Pyridostigmine—Vertigo—Temozolomide—skin cancer	0.000959	0.00462	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000941	0.00453	CcSEcCtD
Pyridostigmine—Paraesthesia—Bleomycin—skin cancer	0.000927	0.00447	CcSEcCtD
Pyridostigmine—Convulsion—Temozolomide—skin cancer	0.000925	0.00446	CcSEcCtD
Pyridostigmine—Vomiting—Imiquimod—skin cancer	0.000924	0.00445	CcSEcCtD
Pyridostigmine—Rash—Imiquimod—skin cancer	0.000916	0.00442	CcSEcCtD
Pyridostigmine—Dermatitis—Imiquimod—skin cancer	0.000916	0.00441	CcSEcCtD
Pyridostigmine—Headache—Imiquimod—skin cancer	0.000911	0.00439	CcSEcCtD
Pyridostigmine—Myalgia—Temozolomide—skin cancer	0.000909	0.00438	CcSEcCtD
Pyridostigmine—Confusional state—Temozolomide—skin cancer	0.000878	0.00423	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.000877	0.00423	CcSEcCtD
Pyridostigmine—Nausea—Imiquimod—skin cancer	0.000863	0.00416	CcSEcCtD
Pyridostigmine—Epistaxis—Docetaxel—skin cancer	0.000857	0.00413	CcSEcCtD
Pyridostigmine—Convulsion—Fluorouracil—skin cancer	0.000852	0.00411	CcSEcCtD
Pyridostigmine—Feeling abnormal—Bleomycin—skin cancer	0.000851	0.0041	CcSEcCtD
Pyridostigmine—Hyperhidrosis—Temozolomide—skin cancer	0.000842	0.00406	CcSEcCtD
Pyridostigmine—Myalgia—Fluorouracil—skin cancer	0.000837	0.00404	CcSEcCtD
Pyridostigmine—Urticaria—Bleomycin—skin cancer	0.00082	0.00395	CcSEcCtD
Pyridostigmine—Hypoaesthesia—Docetaxel—skin cancer	0.000811	0.00391	CcSEcCtD
Pyridostigmine—Confusional state—Fluorouracil—skin cancer	0.000809	0.0039	CcSEcCtD
Pyridostigmine—Feeling abnormal—Dactinomycin—skin cancer	0.000794	0.00383	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000794	0.00383	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Dactinomycin—skin cancer	0.000788	0.0038	CcSEcCtD
Pyridostigmine—Paraesthesia—Temozolomide—skin cancer	0.000782	0.00377	CcSEcCtD
Pyridostigmine—Somnolence—Temozolomide—skin cancer	0.000774	0.00373	CcSEcCtD
Pyridostigmine—Abdominal pain—Dactinomycin—skin cancer	0.000761	0.00367	CcSEcCtD
Pyridostigmine—Hypersensitivity—Bleomycin—skin cancer	0.000761	0.00367	CcSEcCtD
Pyridostigmine—Hypotension—Fluorouracil—skin cancer	0.00075	0.00362	CcSEcCtD
Pyridostigmine—Asthenia—Bleomycin—skin cancer	0.000741	0.00357	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000731	0.00352	CcSEcCtD
Pyridostigmine—Paraesthesia—Fluorouracil—skin cancer	0.000721	0.00347	CcSEcCtD
Pyridostigmine—Alopecia—Docetaxel—skin cancer	0.00072	0.00347	CcSEcCtD
Pyridostigmine—Feeling abnormal—Temozolomide—skin cancer	0.000718	0.00346	CcSEcCtD
Pyridostigmine—Somnolence—Fluorouracil—skin cancer	0.000713	0.00344	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Temozolomide—skin cancer	0.000712	0.00343	CcSEcCtD
Pyridostigmine—Hypersensitivity—Dactinomycin—skin cancer	0.00071	0.00342	CcSEcCtD
Pyridostigmine—Urticaria—Temozolomide—skin cancer	0.000692	0.00334	CcSEcCtD
Pyridostigmine—Asthenia—Dactinomycin—skin cancer	0.000691	0.00333	CcSEcCtD
Pyridostigmine—Abdominal pain—Temozolomide—skin cancer	0.000689	0.00332	CcSEcCtD
Pyridostigmine—Muscle spasms—Docetaxel—skin cancer	0.000682	0.00329	CcSEcCtD
Pyridostigmine—Feeling abnormal—Fluorouracil—skin cancer	0.000661	0.00319	CcSEcCtD
Pyridostigmine—Diarrhoea—Dactinomycin—skin cancer	0.000659	0.00318	CcSEcCtD
Pyridostigmine—Vomiting—Bleomycin—skin cancer	0.000657	0.00316	CcSEcCtD
Pyridostigmine—Rash—Bleomycin—skin cancer	0.000651	0.00314	CcSEcCtD
Pyridostigmine—Dermatitis—Bleomycin—skin cancer	0.00065	0.00314	CcSEcCtD
Pyridostigmine—Hypersensitivity—Temozolomide—skin cancer	0.000642	0.00309	CcSEcCtD
Pyridostigmine—Urticaria—Fluorouracil—skin cancer	0.000638	0.00307	CcSEcCtD
Pyridostigmine—Asthenia—Temozolomide—skin cancer	0.000625	0.00301	CcSEcCtD
Pyridostigmine—Loss of consciousness—Docetaxel—skin cancer	0.000624	0.00301	CcSEcCtD
Pyridostigmine—Convulsion—Docetaxel—skin cancer	0.000615	0.00296	CcSEcCtD
Pyridostigmine—Nausea—Bleomycin—skin cancer	0.000613	0.00296	CcSEcCtD
Pyridostigmine—Vomiting—Dactinomycin—skin cancer	0.000612	0.00295	CcSEcCtD
Pyridostigmine—Rash—Dactinomycin—skin cancer	0.000607	0.00293	CcSEcCtD
Pyridostigmine—Myalgia—Docetaxel—skin cancer	0.000604	0.00291	CcSEcCtD
Pyridostigmine—Diarrhoea—Temozolomide—skin cancer	0.000596	0.00287	CcSEcCtD
Pyridostigmine—Hypersensitivity—Fluorouracil—skin cancer	0.000591	0.00285	CcSEcCtD
Pyridostigmine—Confusional state—Docetaxel—skin cancer	0.000584	0.00282	CcSEcCtD
Pyridostigmine—Nausea—Dactinomycin—skin cancer	0.000572	0.00276	CcSEcCtD
Pyridostigmine—Vomiting—Temozolomide—skin cancer	0.000554	0.00267	CcSEcCtD
Pyridostigmine—Rash—Temozolomide—skin cancer	0.000549	0.00265	CcSEcCtD
Pyridostigmine—Diarrhoea—Fluorouracil—skin cancer	0.000549	0.00265	CcSEcCtD
Pyridostigmine—Dermatitis—Temozolomide—skin cancer	0.000549	0.00264	CcSEcCtD
Pyridostigmine—Headache—Temozolomide—skin cancer	0.000546	0.00263	CcSEcCtD
Pyridostigmine—Hypotension—Docetaxel—skin cancer	0.000541	0.00261	CcSEcCtD
Pyridostigmine—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000528	0.00254	CcSEcCtD
Pyridostigmine—Paraesthesia—Docetaxel—skin cancer	0.00052	0.00251	CcSEcCtD
Pyridostigmine—Nausea—Temozolomide—skin cancer	0.000517	0.00249	CcSEcCtD
Pyridostigmine—Somnolence—Docetaxel—skin cancer	0.000515	0.00248	CcSEcCtD
Pyridostigmine—Vomiting—Fluorouracil—skin cancer	0.00051	0.00246	CcSEcCtD
Pyridostigmine—Rash—Fluorouracil—skin cancer	0.000506	0.00244	CcSEcCtD
Pyridostigmine—Dermatitis—Fluorouracil—skin cancer	0.000506	0.00244	CcSEcCtD
Pyridostigmine—Headache—Fluorouracil—skin cancer	0.000503	0.00242	CcSEcCtD
Pyridostigmine—Feeling abnormal—Docetaxel—skin cancer	0.000477	0.0023	CcSEcCtD
Pyridostigmine—Nausea—Fluorouracil—skin cancer	0.000477	0.0023	CcSEcCtD
Pyridostigmine—Gastrointestinal pain—Docetaxel—skin cancer	0.000474	0.00228	CcSEcCtD
Pyridostigmine—Abdominal pain—Docetaxel—skin cancer	0.000458	0.00221	CcSEcCtD
Pyridostigmine—Hypersensitivity—Docetaxel—skin cancer	0.000427	0.00206	CcSEcCtD
Pyridostigmine—Asthenia—Docetaxel—skin cancer	0.000416	0.002	CcSEcCtD
Pyridostigmine—Diarrhoea—Docetaxel—skin cancer	0.000396	0.00191	CcSEcCtD
Pyridostigmine—Vomiting—Docetaxel—skin cancer	0.000368	0.00178	CcSEcCtD
Pyridostigmine—Rash—Docetaxel—skin cancer	0.000365	0.00176	CcSEcCtD
Pyridostigmine—Dermatitis—Docetaxel—skin cancer	0.000365	0.00176	CcSEcCtD
Pyridostigmine—Headache—Docetaxel—skin cancer	0.000363	0.00175	CcSEcCtD
Pyridostigmine—Nausea—Docetaxel—skin cancer	0.000344	0.00166	CcSEcCtD
